Abbott Labs Bracing for Tariffs as Profits Rise
In This Article:
Abbott Labs boosted its earnings in the first quarter and hinted that its full-year guidance might have gotten a lift were it not for looming cost hikes from the recent tariff war.
Terms and Privacy Policy